SPYRE THERAPEUTICS INC

Ticker: SYRE CUSIP: 00773J202 Class: Common Stock

WELLINGTON MANAGEMENT GROUP LLP's Holding History (CIK: 0000902219)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,549,284 Value ($000) $50,755 Avg Close $26.13 Range $15.86 - $35.31
Q3 2025
Shares 1,640,312 Value ($000) $27,492 Avg Close $16.31 Range $14.00 - $18.30
Q2 2025
Shares 1,513,478 Value ($000) $22,657 Avg Close $14.80 Range $10.91 - $19.20
Q1 2025
Shares 1,593,678 Value ($000) $25,714 Avg Close $20.81 Range $16.13 - $26.01
Q4 2024
Shares 1,604,508 Value ($000) $37,353 Avg Close $29.32 Range $22.37 - $40.26
Q3 2024
Shares 1,507,200 Value ($000) $44,327 Avg Close $27.85 Range $23.00 - $32.41
Q2 2024
Shares 795,946 Value ($000) $18,713 Avg Close $33.73 Range $22.19 - $40.84
Q1 2024
Shares 812,860 Value ($000) $30,832 Avg Close $28.97 Range $18.54 - $47.97
Q4 2023
Shares 635,455 Value ($000) $13,675 Avg Close $13.78 Range $8.43 - $22.66
Q3 2023
Shares 299,929 Value ($000) $3,674 Avg Close $13.22 Range $9.53 - $18.00